Skip to main content
. 2019 Jan 4;25(8):1375–1382. doi: 10.1093/ibd/izy384

FIGURE 1.

FIGURE 1.

Clinical remission and enhanced clinical response after induction treatment in GEMINI 2 and GEMINI 3 comparing (A) vedolizumab and placebo treatment arms (stratified by corticosteroid subgroup) and (B) corticosteroid and no-corticosteroid subgroups (stratified by treatment arm).